Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Duration of Protection Following Five Doses of GlaxoSmithKline's (GSK's) DTaP Vaccines in School Age Children

NCT02447978 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02447978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02447978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Duration of Protection Following Five Doses of GlaxoSmithKline's (GSK's) DTaP Vaccines in School Age Children
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
February 28, 2015
Completion date
June 30, 2015
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, tetanus